tiprankstipranks
Trending News
More News >
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market

Zentalis Pharmaceuticals (ZNTL) Ownership - Who Owns Zentalis Pharmaceuticals?

Compare
316 Followers

Zentalis Pharmaceuticals (ZNTL) Ownership Overview

4.62%18.52%38.55%8.23%30.08%
38.55% Other Institutional Investors
8.23% ETFs
30.08% Public Companies and Individual Investors
The ownership structure of Zentalis Pharmaceuticals (ZNTL) stock is a mix of institutional, retail, and individual investors. Approximately 65.30% of the company’s stock is owned by Institutional Investors, 4.62% is owned by Insiders, and 30.08% is owned by Public Companies and Individual Investors.
The ownership structure of Zentalis Pharmaceuticals (ZNTL) stock is a mix of institutional, retail, and individual investors. Approximately 57.08% of the company’s stock is owned by Institutional Investors, 4.62% is owned by Insiders, and 8.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 30, 2025
xxxxxxxxxxxxx
$29190
Feb 12, 2025
xxxxxxxxxxxxx
$45600
Feb 05, 2025
xxxxxxxxxxxxx
$24569
Feb 05, 2025
xxxxxxxxxxxxx
$22623

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$198433
Mar 31, 2025
xxxxxxxxxxxxx
$2010745

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,959,973Institution19.40%17,589,566
4,465,589Institution6.21%5,626,642
2,956,741Institution4.11%3,725,494
2,475,779Institution3.44%3,119,482
2,045,417Institution2.84%2,577,225
1,264,620Institution1.76%1,593,421
1,129,510Institution1.57%1,423,183
1,070,784Insider1.49%1,349,188
633,680Insider0.88%798,437
629,983Institution0.88%793,779

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,465,589Institution6.21%5,626,642
2,475,779Institution3.44%3,119,482
1,129,510Institution1.57%1,423,183
629,983Institution0.88%793,779
560,565Institution0.78%706,312
540,945Institution0.75%681,591
519,851Institution0.72%655,012
479,440Institution0.67%604,094
459,792Institution0.64%579,338
305,018Institution0.42%384,323

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,579,228Institution2.19%2,242,504
1,521,383Institution2.11%1,916,943
896,551Institution1.25%1,273,102
510,108Institution0.71%642,736
283,114Institution0.39%402,022
258,718Institution0.36%325,985
154,440Institution0.21%219,305
129,251Institution0.18%162,856
122,766Institution0.17%154,685
88,593Institution0.12%111,627

FAQ

Who Owns Zentalis Pharmaceuticals (ZNTL)?
According to the latest TipRanks data, approximately 38.55% of the company's stock is held by institutional investors, 4.62% is held by insiders, and 30.08% is held by retail investors.
    What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 38.55% of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors.
      What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.08% of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors.
        Who owns the most shares of Zentalis Pharmaceuticals (ZNTL)?
        Christopher J. Burke owns the most shares of Zentalis Pharmaceuticals (ZNTL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis